 |
 |

High-Dose Statins and Atherosclerosis Regression
 |
 |
| Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings. |
|
 |
 |
To the Editor: In reporting the results of the ASTEROID trial, Dr Nissen and colleagues1 provide important information about the efficacy of intensive statin therapy with rosuvastatin on atherosclerosis. Two processes occur during atherosclerosis progression: increase in atheroma (which can be measured by average cross-sectional atheroma area in the evaluated segment) and compensatory enlargement of vessel size (which can be measured by average cross-sectional external elastic membrane [EEM] area in the evaluated segment). Both of these values should be provided, as well as the length of the evaluated segment, to be able to compare the results with other studies and to better understand the meaning of the intravascular ultrasound evaluation (including the size and disease severity of the evaluated vessels).
The change in normalized total atheroma volume, reported as the secondary efficacy outcome, cannot be compared with other studies unless the normalization factor (median length of evaluated segment) is provided. . . . [Full Text of this Article]
Yoseph Rozenman, MSc, MD
rozenman@wolfson.health.gov.il The Edith Wolfson Medical Center Tel-Aviv University Holon, Israel
CiteULike Connotea Del.icio.us Digg Reddit Technorati Twitter
What's this?
RELATED ARTICLES
High-Dose Statins in Acute Coronary Syndromes: Not Just Lipid Levels
JAMA. ;292():1365-1367.
FULL TEXT
Effect of Very High-Intensity Statin Therapy on Regression of Coronary Atherosclerosis: The ASTEROID Trial
, , , , , , , , , , , , , , , , and
JAMA. ;295():1556-1565.
FULL TEXT
High-dose statins and atherosclerosis regression.
JAMA. ;296():1836-1836.
FULL TEXT
High-dose statins and atherosclerosis regression.
and
JAMA. ;296():1837-1837.
FULL TEXT
High-Dose Statins and Atherosclerosis Regression--Reply
JAMA. ;296():1837-1837.
FULL TEXT
|